PMID- 20531209 OWN - NLM STAT- MEDLINE DCOM- 20101008 LR - 20220318 IS - 1944-7884 (Electronic) IS - 1525-4135 (Print) IS - 1525-4135 (Linking) VI - 55 IP - 2 DP - 2010 Oct TI - Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1. PG - 182-8 LID - 10.1097/QAI.0b013e3181e222c9 [doi] AB - BACKGROUND: : We compared biomarkers of vascular dysfunction among HIV-infected children to a demographically similar group of uninfected children and determined factors associated with these biomarkers. METHODS AND RESULTS: : We measured several biomarkers of vascular dysfunction: C-reactive protein (CRP), interleukin-6 (IL-6), and monocyte chemoattractant protein -1 (MCP-1) (inflammation); fibrinogen and P-selectin (coagulant dysfunction); soluble intracellular cell adhesion molecule-1 (sICAM), soluble vascular cell adhesion molecule-1 (sVCAM), and E-selectin (endothelial dysfunction); and leptin (metabolic dysfunction). Anthropometry, body composition, CD4%, HIV viral load, and antiretroviral therapy were recorded. Mean age was 14.8 years (106 HIV-infected children) and 12.3 years (55 control children). Sex and body mass index Z scores were similar. Infected children had higher sICAM, sVCAM, MCP-1, IL-6, and fibrinogen levels. E-selectin (P = 0.07), and CRP (P = 0.08) trended to be greater in the HIV group, yet leptin and P-selectin were similar. In multivariable analyses in the HIV-infected children alone, each 1 standard deviation increase in waist to hip ratio was associated with increases in sICAM (17%), MCP-1 (19%), IL6 (18%), and CRP (59%). CD4% was inversely associated with sVCAM, MCP-1, IL6, fibrinogen, and CRP. CONCLUSIONS: : HIV-infected children have higher levels of biomarkers of vascular dysfunction than healthy children. Risk factors associated with these biomarkers include higher waist to hip ratios and HIV disease severity. FAU - Miller, Tracie L AU - Miller TL AD - Division of Pediatric Clinical Research, Department of Pediatrics, Miller School of Medicine, University of Miami, Miami, FL, USA. FAU - Somarriba, Gabriel AU - Somarriba G FAU - Orav, E John AU - Orav EJ FAU - Mendez, Armando J AU - Mendez AJ FAU - Neri, Daniela AU - Neri D FAU - Schaefer, Natasha AU - Schaefer N FAU - Forster, Lourdes AU - Forster L FAU - Goldberg, Ronald AU - Goldberg R FAU - Scott, Gwendolyn B AU - Scott GB FAU - Lipshultz, Steven E AU - Lipshultz SE LA - eng GR - P01 DK045734/DK/NIDDK NIH HHS/United States GR - R01 HL095127/HL/NHLBI NIH HHS/United States GR - 1R01HL095127-01/HL/NHLBI NIH HHS/United States GR - P01DK45734/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - J Acquir Immune Defic Syndr JT - Journal of acquired immune deficiency syndromes (1999) JID - 100892005 RN - 0 (Biomarkers) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (E-Selectin) RN - 0 (Leptin) RN - 0 (P-Selectin) RN - 0 (Vascular Cell Adhesion Molecule-1) RN - 9001-32-5 (Fibrinogen) RN - 9007-41-4 (C-Reactive Protein) SB - IM CIN - Biomark Med. 2010 Oct;4(5):751. PMID: 20945989 MH - Adolescent MH - Biomarkers/*blood MH - Blood Vessels/*physiopathology MH - C-Reactive Protein/analysis MH - Case-Control Studies MH - Chemokine CCL2/blood MH - Child MH - E-Selectin/blood MH - Female MH - Fibrinogen/analysis MH - HIV Infections/*blood/physiopathology MH - *HIV-1 MH - Humans MH - Leptin/blood MH - Male MH - Multivariate Analysis MH - P-Selectin/blood MH - Vascular Cell Adhesion Molecule-1/blood MH - Waist-Hip Ratio PMC - PMC2943965 MID - NIHMS213400 COIS- DISCLOSURES The authors have no potential, perceived, or real conflicts of interest. EDAT- 2010/06/10 06:00 MHDA- 2010/10/12 06:00 PMCR- 2011/10/01 CRDT- 2010/06/10 06:00 PHST- 2010/06/10 06:00 [entrez] PHST- 2010/06/10 06:00 [pubmed] PHST- 2010/10/12 06:00 [medline] PHST- 2011/10/01 00:00 [pmc-release] AID - 10.1097/QAI.0b013e3181e222c9 [doi] PST - ppublish SO - J Acquir Immune Defic Syndr. 2010 Oct;55(2):182-8. doi: 10.1097/QAI.0b013e3181e222c9.